Repligen Corporation (RGEN) Dropped Following the Earnings Release

Repligen Corporation (RGEN) Dropped Following the Earnings Release Soumya Eswaran Wed, June 24, 2026 at 8:51 PM GMT+7 3 min read RGEN ^RUT CL=F Brown Capital Management, an investment management company, released its first quarter 2026 investor letter for “The Brown Capital Management Small Company Fund”. A copy of the letter can be downloaded here. In the first quarter of 2026, the Small Company Fund (Investor shares) fell 19.78%, significantly lagging the Russell 2000 Growth index’s 2.81% decline. Worsened market conditions due to the Iran war, driving the oil price spike and increased volatility in equities. Despite stabilization in the performance as the quarter progressed, early declines and weakness in large positions significantly impacted the Fund’s performance. Please review the Fund’s top five holdings to gain insights into their key selections for 2026.

In its first-quarter 2026 investor letter, The Brown Capital Management Small Company Fund highlighted stocks like Repligen Corporation (NASDAQ:RGEN). Repligen Corporation (NASDAQ:RGEN) is a life science company that develops and distributes bioprocessing technologies and systems. On June 23, 2026, Repligen Corporation (NASDAQ:RGEN) closed at $126.37 per share. One-month return of Repligen Corporation (NASDAQ:RGEN) was 11.66%, and its shares gained 1.89% over the past 52 weeks. Repligen Corporation (NASDAQ:RGEN) has a market capitalization of $7.13 billion.

The Brown Capital Management Small Company Fund stated the following regarding Repligen Corporation (NASDAQ:RGEN) in its Q1 2026 investor letter: